Remedent Stock Performance
| REMI Stock | USD 0.0007 0.0001 16.67% |
Remedent holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of -0.0504, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Remedent are expected to decrease at a much lower rate. During the bear market, Remedent is likely to outperform the market. Use Remedent information ratio, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on Remedent.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Remedent are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady primary indicators, Remedent demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Remedent |
Remedent Relative Risk vs. Return Landscape
If you would invest 0.03 in Remedent on November 9, 2025 and sell it today you would earn a total of 0.04 from holding Remedent or generate 133.33% return on investment over 90 days. Remedent is currently generating 1.7179% in daily expected returns and assumes 10.2061% risk (volatility on return distribution) over the 90 days horizon. In different words, 91% of pink sheets are less volatile than Remedent, and 66% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Remedent Target Price Odds to finish over Current Price
The tendency of Remedent Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0007 | 90 days | 0.0007 | about 8.28 |
Based on a normal probability distribution, the odds of Remedent to move above the current price in 90 days from now is about 8.28 (This Remedent probability density function shows the probability of Remedent Pink Sheet to fall within a particular range of prices over 90 days) .
Remedent Price Density |
| Price |
Predictive Modules for Remedent
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Remedent. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Remedent Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Remedent is not an exception. The market had few large corrections towards the Remedent's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Remedent, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Remedent within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.71 | |
β | Beta against Dow Jones | -0.05 | |
σ | Overall volatility | 0.0001 | |
Ir | Information ratio | 0.16 |
Remedent Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Remedent for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Remedent can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Remedent is way too risky over 90 days horizon | |
| Remedent has some characteristics of a very speculative penny stock | |
| Remedent appears to be risky and price may revert if volatility continues | |
| About 36.0% of the company outstanding shares are owned by corporate insiders |
Remedent Fundamentals Growth
Remedent Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Remedent, and Remedent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Remedent Pink Sheet performance.
| Return On Equity | 0.042 | |||
| Return On Asset | 0.0096 | |||
| Profit Margin | 0.33 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 3.36 M | |||
| Shares Outstanding | 20 M | |||
| Price To Earning | 1.55 X | |||
| Price To Book | 0.75 X | |||
| Price To Sales | 8.46 X | |||
| Revenue | 401.9 K | |||
| EBITDA | 90.24 K | |||
| Cash And Equivalents | 83.3 K | |||
| Total Debt | 9.43 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 0.24 X | |||
| Cash Flow From Operations | 250.56 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 6 M | |||
| Retained Earnings | (21 M) | |||
| Current Asset | 3 M | |||
| Current Liabilities | 3 M |
About Remedent Performance
By evaluating Remedent's fundamental ratios, stakeholders can gain valuable insights into Remedent's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Remedent has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Remedent has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. The company was founded in 1986 and is headquartered in Ghent, Belgium. Remedent operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3 people.Things to note about Remedent performance evaluation
Checking the ongoing alerts about Remedent for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Remedent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Remedent is way too risky over 90 days horizon | |
| Remedent has some characteristics of a very speculative penny stock | |
| Remedent appears to be risky and price may revert if volatility continues | |
| About 36.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Remedent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Remedent's stock is overvalued or undervalued compared to its peers.
- Examining Remedent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Remedent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Remedent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Remedent's pink sheet. These opinions can provide insight into Remedent's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Remedent Pink Sheet analysis
When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |